seek and you will find

  • Home
  • Technology
  • Products 
    • Products Overview
    • SeekInCare
    • SeekInCure
    • SeekInClarity
    • OncoSeek
    • LeukoPrint
  • Publication
  • Newsroom
  • Get in Touch
  • …  
    • Home
    • Technology
    • Products 
      • Products Overview
      • SeekInCare
      • SeekInCure
      • SeekInClarity
      • OncoSeek
      • LeukoPrint
    • Publication
    • Newsroom
    • Get in Touch

     

    seek and you will find

    • Home
    • Technology
    • Products 
      • Products Overview
      • SeekInCare
      • SeekInCure
      • SeekInClarity
      • OncoSeek
      • LeukoPrint
    • Publication
    • Newsroom
    • Get in Touch
    • …  
      • Home
      • Technology
      • Products 
        • Products Overview
        • SeekInCare
        • SeekInCure
        • SeekInClarity
        • OncoSeek
        • LeukoPrint
      • Publication
      • Newsroom
      • Get in Touch

      SeekIn Receives CE-IVD Mark for Cancer Recurrence Monitoring Test

      · Press Releases

      SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, today announced CE (Conformité Européenne) Mark approval for SeekInCure® Cancer Recurrence Monitoring Kit and is now ready to launch this test in European Union and other countries that recognize CE-IVD Mark.

      https://www.precisiononcologynews.com/liquid-biopsy/seekin-receives-ce-ivd-mark-cancer-recurrence-monitoring-test

       

      Previous
      SeekIn Demonstrates the Power of Treatment Response...
      Next
      SeekIn Receives CE-IVD Mark Approval for PanCanSeek®...
       Return to site
      All Posts
      ×

      Almost done…

      We just sent you an email. Please click the link in the email to confirm your subscription!

      OK